Literature DB >> 24938525

Inflammatory bowel disease.

Daniele Corridoni1, Kristen O Arseneau1, Fabio Cominelli2.   

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are chronic, relapsing inflammatory condition of the gastrointestinal tract. CD and UC have distinct pathologic and clinical characteristics and despite the extensive amount of research conducted over the past decades, their pathogenesis remains still poorly understood. So far, the accepted dogma is that IBD results from dysregulated mucosal immune response to environmental factors in genetical susceptible hosts. Various components are implicated in the pathogenesis of IBD, including genetic susceptibility, environmental and microbial factors, intestinal epithelial cells and components of innate and adaptive immune system. Given the complexity of IBD, several different animal models of IBD have been developed during the last years. Animal models are very important tools to study the involvement of various factors in the pathogenesis of IBD and, importantly, to test new therapeutic options. This review examines some of the key components that have been found to be closely associated to IBD and describe the distinct features of some of the most important IBD models.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Animal models; Crohn's disease; Cytokine; Inflammatory bowel disease; Ulcerative colitis

Mesh:

Year:  2014        PMID: 24938525      PMCID: PMC4401421          DOI: 10.1016/j.imlet.2014.04.004

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  50 in total

1.  A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.

Authors:  Richard H Duerr; Kent D Taylor; Steven R Brant; John D Rioux; Mark S Silverberg; Mark J Daly; A Hillary Steinhart; Clara Abraham; Miguel Regueiro; Anne Griffiths; Themistocles Dassopoulos; Alain Bitton; Huiying Yang; Stephan Targan; Lisa Wu Datta; Emily O Kistner; L Philip Schumm; Annette T Lee; Peter K Gregersen; M Michael Barmada; Jerome I Rotter; Dan L Nicolae; Judy H Cho
Journal:  Science       Date:  2006-10-26       Impact factor: 47.728

2.  A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease.

Authors:  R G Shorter; K A Huizenga; R J Spencer
Journal:  Am J Dig Dis       Date:  1972-11

3.  Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial.

Authors:  Paolo Gionchetti; Fernando Rizzello; Ulf Helwig; Alessandro Venturi; Karen Manon Lammers; Patrizia Brigidi; Beatrice Vitali; Gilberto Poggioli; Mario Miglioli; Massimo Campieri
Journal:  Gastroenterology       Date:  2003-05       Impact factor: 22.682

4.  TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis.

Authors:  Mario Noti; Nadia Corazza; Christoph Mueller; Barbara Berger; Thomas Brunner
Journal:  J Exp Med       Date:  2010-05-03       Impact factor: 14.307

5.  Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis.

Authors:  Ivan J Fuss; Frank Heller; Monica Boirivant; Francisco Leon; Masaru Yoshida; Stefan Fichtner-Feigl; Zhiqiong Yang; Mark Exley; Atsushi Kitani; Richard S Blumberg; Peter Mannon; Warren Strober
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

6.  Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease.

Authors:  Naohiro Inohara; Yasunori Ogura; Ana Fontalba; Olga Gutierrez; Fernando Pons; Javier Crespo; Koichi Fukase; Seiichi Inamura; Shoichi Kusumoto; Masahito Hashimoto; Simon J Foster; Anthony P Moran; Jose L Fernandez-Luna; Gabriel Nuñez
Journal:  J Biol Chem       Date:  2003-01-04       Impact factor: 5.157

7.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

8.  Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation.

Authors:  Olga Gutierrez; Carlos Pipaon; Naohiro Inohara; Ana Fontalba; Yasunori Ogura; Felipe Prosper; Gabriel Nunez; Jose L Fernandez-Luna
Journal:  J Biol Chem       Date:  2002-08-22       Impact factor: 5.157

Review 9.  NOD2, an intracellular innate immune sensor involved in host defense and Crohn's disease.

Authors:  W Strober; T Watanabe
Journal:  Mucosal Immunol       Date:  2011-07-13       Impact factor: 7.313

10.  Probiotic bacteria regulate intestinal epithelial permeability in experimental ileitis by a TNF-dependent mechanism.

Authors:  Daniele Corridoni; Luca Pastorelli; Benedetta Mattioli; Silviu Locovei; Dai Ishikawa; Kristen O Arseneau; Marcello Chieppa; Fabio Cominelli; Theresa T Pizarro
Journal:  PLoS One       Date:  2012-07-25       Impact factor: 3.240

View more
  48 in total

1.  SGK1 inhibits cellular apoptosis and promotes proliferation via the MEK/ERK/p53 pathway in colitis.

Authors:  Jian-An Bai; Gui-Fang Xu; Li-Jun Yan; Wei-Wen Zeng; Qian-Qian Ji; Jin-Dao Wu; Qi-Yun Tang
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

Review 2.  Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.

Authors:  Akiko Yamada; Rieko Arakaki; Masako Saito; Takaaki Tsunematsu; Yasusei Kudo; Naozumi Ishimaru
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  GLP-1 nanomedicine alleviates gut inflammation.

Authors:  Arivarasu N Anbazhagan; Mentor Thaqi; Shubha Priyamvada; Dulari Jayawardena; Anoop Kumar; Tarunmeet Gujral; Ishita Chatterjee; Edurne Mugarza; Seema Saksena; Hayat Onyuksel; Pradeep K Dudeja
Journal:  Nanomedicine       Date:  2016-08-20       Impact factor: 5.307

Review 4.  An evidence-based update on the pharmacological activities and possible molecular targets of Lycium barbarum polysaccharides.

Authors:  Jiang Cheng; Zhi-Wei Zhou; Hui-Ping Sheng; Lan-Jie He; Xue-Wen Fan; Zhi-Xu He; Tao Sun; Xueji Zhang; Ruan Jin Zhao; Ling Gu; Chuanhai Cao; Shu-Feng Zhou
Journal:  Drug Des Devel Ther       Date:  2014-12-17       Impact factor: 4.162

5.  Distribution and phylogenetic analysis of Blastocystis sp. subtypes isolated from IBD patients and healthy individuals in Iran.

Authors:  H Mirjalali; M R Abbasi; N Naderi; Z Hasani; E S Mirsamadi; C R Stensvold; H Balaii; H Asadzadeh Aghdaei; M R Zali
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-07-25       Impact factor: 3.267

Review 6.  Mesenchymal stem cells in the treatment of inflammatory and autoimmune diseases in experimental animal models.

Authors:  Matthew W Klinker; Cheng-Hong Wei
Journal:  World J Stem Cells       Date:  2015-04-26       Impact factor: 5.326

Review 7.  Pathophysiology of Eosinophilic Esophagitis.

Authors:  Benjamin P Davis
Journal:  Clin Rev Allergy Immunol       Date:  2018-08       Impact factor: 8.667

8.  Immunology of Gut-Bone Signaling.

Authors:  Fraser L Collins; Jonathan D Schepper; Naiomy Deliz Rios-Arce; Michael D Steury; Ho Jun Kang; Heather Mallin; Daniel Schoenherr; Glen Camfield; Saima Chishti; Laura R McCabe; Narayanan Parameswaran
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

9.  Beneficial Effects of Fecal Microbiota Transplantation on Ulcerative Colitis in Mice.

Authors:  Zhihui Tian; Jie Liu; Mengyu Liao; Wenjuan Li; Jiaqi Zou; Xinxin Han; Mingjie Kuang; Wanqiu Shen; Haidong Li
Journal:  Dig Dis Sci       Date:  2016-02-05       Impact factor: 3.199

10.  Neutralization of pro-inflammatory monocytes by targeting TLR2 dimerization ameliorates colitis.

Authors:  Liraz Shmuel-Galia; Tegest Aychek; Avner Fink; Ziv Porat; Batya Zarmi; Biana Bernshtein; Ori Brenner; Steffen Jung; Yechiel Shai
Journal:  EMBO J       Date:  2016-02-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.